The FDA has granted Breakthrough Therapy Designation to Amicus Therapeutics’ (NASDAQ:FOLD) AT-GAA for the treatment of late onset Pompe disease. AT-GAA is the first ever investigational...
U.S. stocks rebounded during afternoon trading on Friday. A rally in health care and energy stocks outweighed early concerns about the economy after a disappointing jobs...